Taiwan-based Stereotactic surgery navigation solution developer EPED has been tapping overseas markets and expects consolidated revenues for 2020 to exceed NT$100 million (US$3.3 million), according to company chairman and president Douglas Huang.
The article requires paid subscription. Subscribe Now
